The Daily Tribune News6h
Dr. Roach: How polycystic ovary syndrome affects older women
I had all the symptoms of polycystic ovary syndrome (PCOS) when I was younger. I could go six months without having my period ...
Curly, unruly, fast-growing. For women, chin hair is normal. But when might it signal a health issue?
One potential culprit of chin hair is polycystic ovary syndrome (PCOS), which impacts around 8 to 13% of women of ...
Her17h
PCOS, Endometriosis, and Adenomyosis Warrior Sarah Jane Allen shares her story
One woman who knows how that feels is Sarah Jane Allen. Sarah has faced major health struggles in her three decades and is ...
Endocrinology Advisor17h
PCOS and Diabetes
Both PCOS and diabetes can be difficult to control and require highly individualized treatment, depending on the patient's ...
Gwinnett Daily Post22h
Georgia Has the 5th Highest Rate of GLP-1 Use in the Nation
This could lead to FDA approvals for treatment in obstructive sleep apnea, kidney disease, Alzheimer’s disease, liver disease ...
Grand Rapids Herald-Review1d
Minnesota Has the 13th Lowest Rate of GLP-1 Use in the Country
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Hastings Tribune1d
Kansas Residents Are Using GLP-1s at an Above Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Hastings Tribune1d
Nebraska Residents Are Using GLP-1s at a Slightly Above Average Rate
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Messenger-Inquirer1d
Kentucky Has the Highest Rate of GLP-1 Use in the Country
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Grainger County1d
Tennessee Residents Are Using GLP-1s at the 13th Highest Rate in the Country
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Endocrinology Advisor1d
Missed Diagnosis of PCOS Tied to Race and Socioeconomic Vulnerability Factors
Missed diagnosis of PCOS was associated with Black vs White race, Medicaid vs private insurance, and normal BMI vs overweight BMI.